Tg Therapeutics (TGTX) EBITDA Margin Growth (3y) (2020 - 2026)
Tg Therapeutics (TGTX) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 49,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,105.00 |
| Dec 31, 2025 | 9.69 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 658,041.00 |
| Mar 31, 2025 | 332,420.00 |
| Dec 31, 2024 | 403,229.00 |
| Sep 30, 2024 | 420,832.00 |
| Jun 30, 2024 | 502,766.00 |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 22.83 Mn |
| Sep 30, 2023 | 22.57 Mn |
| Jun 30, 2023 | 13.35 Mn |
| Mar 31, 2023 | 13.17 Mn |
| Dec 31, 2022 | 297,362.00 |
| Sep 30, 2022 | 12.30 Mn |
| Jun 30, 2022 | 8.70 Mn |
| Mar 31, 2022 | 8.80 Mn |
| Dec 31, 2021 | 13.85 Mn |
| Sep 30, 2021 | 8.61 Mn |
| Jun 30, 2021 | -12.17 Mn |